Medicine

A. James Hudspeth, winner of the 2018 Kavli Prize in Neuroscience, spoke with Scientific American editor emerita Mariette DiChristina about his efforts to regenerate lost or damaged inner-ear cells that make hearing possible. They also discussed the cultural cohesion of the deaf community and why, for its members, the lack of aural communication is not a problem requiring a solution.

Two new vaccines are in development, but it has taken researchers two decades to get this close

The three-drug regimen cures 90 percent of people who have the deadliest form of the disease

A genetic therapy that increases or lowers levels of a protein raises hopes for a treatment for neurological disorders

People who receive either therapy soon after infection have a 90 percent survival rate, a clinical trial finds

Nearly half of bacteria gathered in public settings around the city were resistant to two or more commonly used antibiotics, such as penicillin and erythromycin. Christopher Intagliata reports.

Principles of evolution and natural selection drive a radical new approach to drugs and prevention strategies

Our aggressive, expensive approach to cancer is doing more harm than good

But strong regulation is a must to protect patient safety

A surprising resurgence of psychedelic research has produced its first FDA-approved treatment, with more likely on the way

The drug-resistant form of the virus has been detected at unacceptable levels across Africa, Asia and the Americas

Although the hormone has few serious short-term side effects, its long-term risks remain a black box